StockData
Johnson & Johnson logo

Johnson & Johnson (JNJ) stock

JNJNYSEPharmaceutical PreparationsFiscal year ends January 3
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 27, 2026Last filing: 10-Q on Oct 21, 2026Score 12/3083% above fair value
$272.70−6.00 (-2.15%)

Close on Nov 18, 2026Market cap $656.47BP/E 41.4Yield 1.88%

Johnson & Johnson price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Johnson & Johnson's price to sales ratio was 6.9× on Nov 11, 2026, against 5.4× a year earlier. Over the last 5 years it ranged from 4.0× to 6.9×, with a median of 5.2×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20266.9×+1.5
2025Dec 31, 20255.4×+1.4
2024Dec 31, 20244.0×−0.9
2023Dec 29, 20234.9×−1.9
2022Dec 30, 20226.7×+1.7
2021Dec 31, 20215.0×−0.2
2020Dec 31, 20205.2×+0.4
2019Dec 31, 20194.8×+0.5
2018Dec 31, 20184.3×−0.8
2017Dec 29, 20175.2×+0.7
2016Dec 30, 20164.5×+0.4
2015Dec 31, 20154.1×+0.1
2014Dec 31, 20144.0×+0.3
2013Dec 31, 20133.7×+0.8
2012Dec 31, 20123.0×−0.0
2011Dec 30, 20113.0×+0.2
2010Dec 31, 20102.8×−0.2
2009Dec 31, 20093.0×–

More Johnson & Johnson figures

See a number that looks wrong?